Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases

NCT02132598 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Trial stopped due to slow patient accrual.

Conditions

Non Small Cell Lung Cancer (NSCLC)
Metastases to the Brain

Interventions

DRUG: cabozantinib

Sponsor

Liza Villaruz, MD

Collaborators

[object Object]